We are live on ! Find out more
TGI

TRV GP III Portfolio holdings

AUM $6.14M Turnover 0%
1-Year Est. Return 45.44%
This Fund
S&P 500
This Quarter Est. Return
+4.44%
1 Year Est. Return
+45.44%
3 Year Est. Return
+169.98%
5 Year Est. Return
+802.39%
10 Year Est. Return
–
AUM
$6.14M
AUM Growth
+$261K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
3.5 years
Top 10 Avg Time Held
3.5 years
Top 20 Avg Time Held
3.5 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PLRX icon
1
Pliant Therapeutics
PLRX
$55.6M
$6.14M 100%
339,160
– –
2020 Q2
14 quarters

Similar funds

TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.5M AUM 805.26% 1-Year Est. Return
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

TRV GP III's Q4 2023 Portfolio in Review

As of Q4 2023, TRV GP III held 1 position worth $6.14M, up 4.4% from $5.88M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. TRV GP III opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP III's ten largest holdings make up 100% of its $6.14M portfolio in Q4 2023.
  • TRV GP III opened 0 new positions and closed 0 in Q4 2023.
  • TRV GP III's portfolio value rose 4.4% quarter-over-quarter to $6.14M.

Based on TRV GP III's 13F filing for Q4 2023, filed 14 Feb 2024.